Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 9919062 Oncolytic vaccinia virus cancer therapy

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Date Filed
December 11, 2015
Date of Patent
March 20, 2018
Patent Application Number
14966691
Patent Citations Received
‌
US Patent 11986503 Replication competent attenuated vaccinia viruses with deletion of thymidine kinase with and without the expression of human Flt3L or GM-CSF for cancer immunotherapy
0
‌
US Patent 11884939 Vaccinia virus mutants useful for cancer immunotherapy
0
‌
US Patent 12129288 Polynucleotides heterodimers of soluble interferon receptors and uses thereof
0
‌
US Patent 12077790 Optimized binuclease fusions and methods
0
‌
US Patent 11865081 Oncolytic viral delivery of therapeutic polypeptides
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
9919062
Patent Primary Examiner
‌
Scott Long

Find more entities like US Patent 9919062 Oncolytic vaccinia virus cancer therapy

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.